AU2016264220A1 - Heterocyclic compounds as kinase inhibitors - Google Patents
Heterocyclic compounds as kinase inhibitors Download PDFInfo
- Publication number
- AU2016264220A1 AU2016264220A1 AU2016264220A AU2016264220A AU2016264220A1 AU 2016264220 A1 AU2016264220 A1 AU 2016264220A1 AU 2016264220 A AU2016264220 A AU 2016264220A AU 2016264220 A AU2016264220 A AU 2016264220A AU 2016264220 A1 AU2016264220 A1 AU 2016264220A1
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- cycloalkyl
- cancer
- compound
- nhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 Cc1c(*)c(C)n[n]1* Chemical compound Cc1c(*)c(C)n[n]1* 0.000 description 6
- YCICMZULRKRDAP-UHFFFAOYSA-N CC1(N)N=CC=C(c2cc(NC(NCc3cccc(OC)c3)=O)n[nH]2)N1 Chemical compound CC1(N)N=CC=C(c2cc(NC(NCc3cccc(OC)c3)=O)n[nH]2)N1 YCICMZULRKRDAP-UHFFFAOYSA-N 0.000 description 1
- DTGFGXONMBQLNP-UHFFFAOYSA-N COc1cc(C(CO)Nc2nc(cc(cc3)-c4ccncc4)c3[nH]2)ccc1 Chemical compound COc1cc(C(CO)Nc2nc(cc(cc3)-c4ccncc4)c3[nH]2)ccc1 DTGFGXONMBQLNP-UHFFFAOYSA-N 0.000 description 1
- CAZDOEYDQUBZHQ-UHFFFAOYSA-N COc1cc(CNc2nc3cc(-c4c[nH]nc4)ccc3[nH]2)ccc1 Chemical compound COc1cc(CNc2nc3cc(-c4c[nH]nc4)ccc3[nH]2)ccc1 CAZDOEYDQUBZHQ-UHFFFAOYSA-N 0.000 description 1
- AEAPHLHYFOQMOJ-UHFFFAOYSA-N COc1cccc(C(CO)Nc2nc3cc(-c4c[nH]nc4)ccc3[nH]2)c1 Chemical compound COc1cccc(C(CO)Nc2nc3cc(-c4c[nH]nc4)ccc3[nH]2)c1 AEAPHLHYFOQMOJ-UHFFFAOYSA-N 0.000 description 1
- SQSXMQRLEVAWFY-UHFFFAOYSA-N COc1cccc(CNc2nc3cc(-c4ccncc4)ccc3[nH]2)c1 Chemical compound COc1cccc(CNc2nc3cc(-c4ccncc4)ccc3[nH]2)c1 SQSXMQRLEVAWFY-UHFFFAOYSA-N 0.000 description 1
- QWNLPGSJEPPKJE-UHFFFAOYSA-N C[n](c(-c1ccncc1)c1)nc1C(NC(CO)c1cccc(F)c1)=O Chemical compound C[n](c(-c1ccncc1)c1)nc1C(NC(CO)c1cccc(F)c1)=O QWNLPGSJEPPKJE-UHFFFAOYSA-N 0.000 description 1
- RXULGNQTUAZQDE-UHFFFAOYSA-N Nc1nccc(-c2cc(C(NCc3cccc(F)c3)=O)n[nH]2)n1 Chemical compound Nc1nccc(-c2cc(C(NCc3cccc(F)c3)=O)n[nH]2)n1 RXULGNQTUAZQDE-UHFFFAOYSA-N 0.000 description 1
- JERLZXUENLHEIU-UHFFFAOYSA-N O=C(c1n[nH]c(-c2ccncc2)c1)NCCc1cc(Cl)ccc1 Chemical compound O=C(c1n[nH]c(-c2ccncc2)c1)NCCc1cc(Cl)ccc1 JERLZXUENLHEIU-UHFFFAOYSA-N 0.000 description 1
- FAVTVHYEDNZNJA-UHFFFAOYSA-N OCC(c1cc(F)ccc1)Nc1nc2cc(-c3c[nH]nc3)ccc2[nH]1 Chemical compound OCC(c1cc(F)ccc1)Nc1nc2cc(-c3c[nH]nc3)ccc2[nH]1 FAVTVHYEDNZNJA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562163369P | 2015-05-18 | 2015-05-18 | |
| US62/163,369 | 2015-05-18 | ||
| US201562203070P | 2015-08-10 | 2015-08-10 | |
| US62/203,070 | 2015-08-10 | ||
| PCT/US2016/033111 WO2016187324A1 (en) | 2015-05-18 | 2016-05-18 | Heterocyclic compounds as kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2016264220A1 true AU2016264220A1 (en) | 2018-01-04 |
Family
ID=57320732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016264220A Abandoned AU2016264220A1 (en) | 2015-05-18 | 2016-05-18 | Heterocyclic compounds as kinase inhibitors |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10392402B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3297437A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2018515623A (cg-RX-API-DMAC7.html) |
| CN (1) | CN107835637A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016264220A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3024113A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1248070A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL255750A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016187324A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210069016A1 (en) * | 2008-11-13 | 2021-03-11 | Gholam A. Peyman | Neurodegenerative Disorder Treatment Method |
| PE20170143A1 (es) | 2014-02-11 | 2017-03-19 | Bayer Pharma AG | Benzimidazol-2-aminas como inhibidores de midh1 |
| CN105980365B (zh) | 2014-02-11 | 2019-06-21 | 拜耳医药股份公司 | 作为mIDH1抑制剂的苯并咪唑-2-胺 |
| AU2016264220A1 (en) * | 2015-05-18 | 2018-01-04 | Translational Drug Development Llc | Heterocyclic compounds as kinase inhibitors |
| AU2020273376C1 (en) * | 2016-10-24 | 2024-02-29 | Translational Drug Development, Llc | Amide compounds as kinase inhibitors, compositions and methods of treatment |
| WO2018094362A1 (en) | 2016-11-21 | 2018-05-24 | Translational Drug Development, Llc | Heterocyclic compounds as kinase inhibitors |
| JP7490569B2 (ja) * | 2018-04-24 | 2024-05-27 | トランスレイショナル・ドラッグ・ディベロップメント・エルエルシー | キナーゼ阻害剤としてのアミド化合物、組成物および処置方法 |
| WO2020142745A1 (en) * | 2019-01-04 | 2020-07-09 | Translational Drug Development, Llc | Methods of treating graft versus host disease and neoplastic disease with amide compounds |
| CN114728926A (zh) * | 2019-11-15 | 2022-07-08 | 武汉朗来科技发展有限公司 | 一种rock抑制剂及其制备方法和用途 |
| CN113121443B (zh) | 2019-12-31 | 2024-07-09 | 财团法人工业技术研究院 | β-氨基酸衍生物、含其之激酶抑制剂与医药组合物以及其用途 |
| AU2021206651B2 (en) * | 2020-01-07 | 2024-02-22 | Disarm Therapeutics, Inc. | Inhibitors of SARM1 |
| EP4192828A1 (en) | 2020-08-04 | 2023-06-14 | Nura Bio, Inc. | Substituted pyridine derivatives as sarm1 inhibitors |
| WO2022060812A1 (en) | 2020-09-16 | 2022-03-24 | Nura Bio, Inc. | Substituted pyridine derivatives as sarm1 inhibitors |
| KR20240041987A (ko) | 2021-07-28 | 2024-04-01 | 누라 바이오, 인크. | Sarm1 억제제로서 치환된 피리딘 유도체 |
| KR20240176853A (ko) * | 2023-06-15 | 2024-12-26 | 현대자동차주식회사 | 이중 전원 공급 장치, 그를 포함한 시스템 및 그 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101253152A (zh) | 2005-09-02 | 2008-08-27 | 安斯泰来制药株式会社 | 作为rock抑制剂的酰胺衍生物 |
| EP2234487A4 (en) | 2007-12-19 | 2011-09-07 | Scripps Research Inst | ANILIDES AND ANALOGUES AS INHIBITORS OF RHO KINASE |
| US20090258907A1 (en) * | 2008-04-09 | 2009-10-15 | Abbott Laboratories | Compounds useful as inhibitors of rock kinases |
| US20130129677A1 (en) * | 2009-02-27 | 2013-05-23 | Siga Technologies, Inc. | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
| AR078793A1 (es) * | 2009-10-27 | 2011-12-07 | Orion Corp | Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros |
| US9221808B2 (en) * | 2010-04-16 | 2015-12-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use |
| US8697911B2 (en) | 2010-07-07 | 2014-04-15 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
| US9284298B2 (en) * | 2011-04-11 | 2016-03-15 | Nerviano Medical Sciences S.R.L. | Pyrazolyl-pyrimidine derivatives as kinase inhibitors |
| AU2016264220A1 (en) * | 2015-05-18 | 2018-01-04 | Translational Drug Development Llc | Heterocyclic compounds as kinase inhibitors |
-
2016
- 2016-05-18 AU AU2016264220A patent/AU2016264220A1/en not_active Abandoned
- 2016-05-18 WO PCT/US2016/033111 patent/WO2016187324A1/en not_active Ceased
- 2016-05-18 JP JP2018512823A patent/JP2018515623A/ja not_active Withdrawn
- 2016-05-18 EP EP16797227.2A patent/EP3297437A4/en not_active Withdrawn
- 2016-05-18 US US15/574,800 patent/US10392402B2/en active Active
- 2016-05-18 HK HK18107657.9A patent/HK1248070A1/zh unknown
- 2016-05-18 CN CN201680041168.4A patent/CN107835637A/zh active Pending
- 2016-05-18 CA CA3024113A patent/CA3024113A1/en not_active Abandoned
-
2017
- 2017-11-19 IL IL255750A patent/IL255750A/en unknown
-
2019
- 2019-08-26 US US16/551,694 patent/US10633393B2/en active Active
-
2020
- 2020-04-27 US US16/859,977 patent/US20200255448A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA3024113A1 (en) | 2016-11-24 |
| US20200255448A1 (en) | 2020-08-13 |
| JP2018515623A (ja) | 2018-06-14 |
| US10633393B2 (en) | 2020-04-28 |
| IL255750A (en) | 2018-01-31 |
| WO2016187324A1 (en) | 2016-11-24 |
| US20180141959A1 (en) | 2018-05-24 |
| US10392402B2 (en) | 2019-08-27 |
| CN107835637A (zh) | 2018-03-23 |
| EP3297437A4 (en) | 2019-02-27 |
| HK1248070A1 (zh) | 2018-10-12 |
| US20200017520A1 (en) | 2020-01-16 |
| EP3297437A1 (en) | 2018-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10633393B2 (en) | Heterocyclic compounds as kinase inhibitors | |
| US10807966B2 (en) | Heterocyclic compounds as kinase inhibitors | |
| CA2441501C (en) | Rho-kinase inhibitors | |
| WO2002076976A2 (en) | Rho-kinase inhibitors | |
| CA2688326C (en) | Tetrahydroisoquinolin-1-one derivative or salt thereof | |
| KR20210150491A (ko) | 포스파티딜이노시톨 3-키나제 저해제 | |
| CN102712601A (zh) | 化合物、其制备方法、药物组合物、化合物的用途、用于调节或调控丝氨酸/苏氨酸激酶的方法以及丝氨酸/苏氨酸激酶调节剂 | |
| US20110212973A1 (en) | Carbamate compound or salt thereof | |
| US20230066011A1 (en) | Pyrrolopyrimidine derivative, and pharmaceutical composition for preventing or treating protein kinase-related disease comprising same as active ingredient | |
| CA2863517A1 (en) | Substituted pyrimidine compounds and their use as syk inhibitors | |
| CA3078347A1 (en) | Amide compounds as kinase inhibitors | |
| CN103857658B (zh) | 作为代谢型谷氨酸受体调节剂的乙炔基衍生物 | |
| WO2023051648A1 (zh) | 可用作shp2抑制剂的化合物及其制备方法和用途 | |
| CN114599655B (zh) | 咪唑烷酮类化合物及其制备方法与应用 | |
| JP7490569B2 (ja) | キナーゼ阻害剤としてのアミド化合物、組成物および処置方法 | |
| US11078161B2 (en) | Rock-inhibiting compound and uses thereof | |
| HK40013991A (en) | Heterocyclic compounds as kinase inhibitors | |
| HK40076191A (en) | Imidazolidinone compound, preparation method therefor and use thereof | |
| AU2021302681A1 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |